Zusammenfassung
Das Alter selbst stellt einen wichtigen Risikofaktor für die Entwicklung der koronaren Herzerkrankung dar (Doyle 1980). Inzidenz und Prävalenz nehmen im Alter zu. Die koronare Herzkrankheit wird klinisch bei etwa 15% der Männer und 9% der Frauen im Alter von 70 Jahren diagnostiziert (Agner 1985). Mit 80 Jahren steigt der Prozentsatz auf 20% bei gleicher Geschlechtsverteilung an.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Abernethy DR, Schwartz JB, Todd EL (1986) Verapamil pharmacodynamics and disposition in young and elderly hypertensive patients. Altered electrocardiographic and hypotensive responses. Ann Intern Med 105:329
Agner E (1985) Epidemiology of coronary heart disease in the elderly patient. In: Coodley EL (ed) Geriatric Heart Disease. Littleton, MA. PSG Publishing Co., pp 114
AIMS trial study group (1988) Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. Lancet 1:545
Alpert JS (1990) Nitrate therapy in the elderly. Am J Cardiol 65:23J
Amende I, Simon R, Hood WP jr, Daniel W, Lichtlen PR (1984) Hämodynamik unter Ischämie: Diastolische Phase. Z Kardiol 73, Suppl 2: 127
Aronow WS, Starling L, Etienne F, D’Alba P, Edwards M, Lee NH, Parungao RF (1985) Unrecognized Q-Wave myocardial infarction in patients older than 64 years in a long-term health-care facility. Am J Cardiol 56:483
Aronow WS (1987) Prevalence of presenting symptoms of recognized acute myocardial infarction and of unrecognized healed myocardial infarction in elderly patients. Am J Cardiol 60:1182
Aronow WS, Epstein S (1988) Usefulness of silent myocardial ischemia detected by ambulatory electrocardiographic monitoring in predicting new coronary events in elderly patients. Am J Cardiol 62: 1295
β-Blocker Heart Attack Study Group (1989) The β-Blocker Heart Attack Trial. JAMA 246:2073
Baughman KL, Marokko PR, Vatner SF (1981) Effects of coronary artery reperfusion on myocardial infarct site and survival in conscious dogs. Circulation 63: 317
Bassenge E, Stewart DJ (1988) Interdependence of pharmacologically-induced and endothelium-mediated coronary vasodilation in antianginal therapy. Cardiovasc Drugs Ther 2: 27
Castleden CN, George CJ (1979) The effects of aging on the hepatic clearance of propranolol. Br J Clin Pharmacol Z: 49
Chiariello M, Volpe M, Rengo F (1979) Effect of furosemide on plasma concentration and β-blockade by propranolol. Clin Pharmacol Ther 26:433
Coodley EL, Zebari D (1985) Characteristics of myocardial infarction in the elderly. In: Coodley EL (ed) Geriatric Heart Disease. Littleton MA: PSG Publishing CO, pp 334
Coodley EL (1990) Coronary artery disease in the elderly. Postgrad Med 87:223
Danish Study Group on Verapamil in Myocardial Infarction (1990) Secondary prevention with Verapamil after myocardial infarction. Am J Cardiol 66:331
Dayton S, Pearce ML, Hashimoto S (1969) A controlled clinical trial of a diet high in unsaturated fat in preventing the complication of atherosclerosis. Circulation 50, Suppl 2: II–63
De Wood MA, Spores J, Notske RN, Mouser LT, Burroughs R, Mohindin S (1979) Incidence of total coronary occlusion and thrombosis in the early phase of acute transmural myocardial infarction. Clin Res 27: 162
Doyle TR (1980): Incidence of coronary heart disease, stroke, and peripheral vascular disease. In: Dawber TR (ed) The Framingham Study: The Epidemiology of Atherosclerotic Disease. Cambridge MA: Harvard University Press, pp 59
Feely J, Wilkinson GR, Wood AJJ (1981) Reduction of liver flow and propranolol metabolism by cimetidine. N Engl J Med 304:692
Fitzgerald JD (1988) Age related effects of β-blockers and hypertension. J Cardiovasc Pharmacol 12: S 83
Frishman WH, Charlap S, Kimmel B (1986) Calcium-channel blockers for combined angina pectoris and systemic hypertension. Am J Cardiol 57: 22D
Gersh BJ, Krommal RA, Schaff HV (1985) Comparison of coronary artery by pass surgery and medical therapy in patients 65 years of age or older. A nonrandomized study from the coronary artery surgery (CASS) registry. N Engl J Med 313:217
Gibson RS, Boden WE, Theroux P (1986) Diltiazem and reinfarction in patients with non-Q-wave- myocardial infarction. Results of a double-blind, randomized trial. N Engl J Med 315:423
Goldberg RJ, Gore JM, Gurwitz JH (1989) The impact of age on the incidence and prognosis of initial acute myocardial infarction. The Worcester Heart Attack Study. Am Heart J 117:543
Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR (1977) Predicting coronary heart disease in middle-aged and older persons. The Framingham Study. JAMA 238:497
Greenblatt DJ, Koch-Weser J (1973) Adverse reaction to propranolol in hospitalized medical patients: a report from the Boston Collaborative Drug Surveillance Program. Am Heart J 86:478
Griffin SJ, Freidman MJ (1986) Depressive symptoms in propranolol users. J Clin Psychiatr 47:453
Gruppo Italiano por la studio della Streptochinasi nell’infarcto miocardico (GISSI) (1987) Long-term effects of intravenous thrombolysis in acute myocardial infarction: final report of the GISSI study. Lancet 2:871
Gurwitz JH, Goldberg RJ, Gore JM (1991) Coronary thrombolysis for the elderly? JAMA 265:1720
Hamby RJ, Hamby B, Hoffman J (1986) Symptomatic coronary disease for 20 or more years: clinical aspects, angiographic findings and therapeutic implications. Am Heart J 112: 65
Hjalmarson A, Elmfeldt D, Herlitz J, Holmberg S, Malek J, Nyberg G, Ryden L, Swedberg K, Vedin A, Waagstein F, Waldenström A, Waldenström J, Wedel H, Wilhelmsen L, Wilhelmsson C (1981) Effect on mortality of metoprolol in acute myocardial infarction: a double-blind, randomized trial. Lancet II: 823
ISIS-2 (Second International Study of Infarct survival) Colloborative Group (1988) Randomised trial of intravenous streptokinase, oral asprin, both, or neither among 17, 107 cases of suspected acute myocardial infarction: ISIS-2. Lancet 2: 349
Kannel WB, Abbot RD (1984) Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham Study. N Engl J Med 311: 1144
Kannel WB, Dannenberg AL, Abbot RD (1985) Unrecognized myocardial infarction and hypertension. The Framingham Study. Am Heart J 109:581
Kannel WB, Doyle JT, Shepard RJ, Stamler J, Vokonas PS (1987) Prevention of cardiovascular disease in the elderly. JACC 10:25A
Kapantais G, Powell-Grimer E (1989) Characteristics of persons dying of diseases of the heart. National Mortality Follow-up survey 1986. Hyatsville, MD: National Center for Health Statistics, p. 172
Kukovetz WR, Holzmann S, Wurm A, Pöch G (1979) Evidence for cyclic GMP-mediated relaxant effects of nitrocompounds in coronary smooth muscle. Naunyn Schmiedebergs Arch Pharmacol 310: 129
Kupper W, Bleifeld W (1982) Myokardinfarkt. Diagnose, Therapie und Prognose. Perimed Fachbuch, Erlangen
La Croix AZ, Guralnik JM, Curb JD, Wallace RB, Ostfeld AM, Hennekens CH (1990) Chest pain and coronary heart disease mortality among older men and women in three Communities. Circulation 81:437
Lipsitz LA, Wei JY, Rowe JW (1985) Syncope in an elderly institutionalized population: Prevalence, incidence and associated risk. Q J Med 55:45
Mac Donald JB, Baillie J, Williams BO, Ballantyne D (1983) Coronary care in the elderly. Age Ageing 12: 17
Mc Lean AJ, Skews H, Bobik A (1980) Interaction between oral propranolol and hydralazine. Clin Pharmacol Ther 27: 726
Packer M, Lee WH, Kessler PD, Gottlieb SS, Medina N, Jushak M (1987) Prevention and reversal of nitrate tolerance in patients with congestive heart failure. N Engl J Med 317:799
Palmer RMJ, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium derived relaxing factor. Nature 327: 524
Parker JO, Farrell B, Lahey KA, Moe G (1987) Effect of intervals between doses on the development of tolerance to isosorbide dinitrate. N Engl J Med 316: 1440
Pathy MS (1967) Clinical presentation of myocardial infarction in the elderly. Br Heart J 29: 190
Pieper JA (1984) Serum protein binding interactions between propranolol and calcium channel blockers. Drug Intell Clin Pharm 18: 492
Rees AP, Lavie CJ, Pepine CJ (1993) Coronary artery disease. In: Messerli FH (ed) Cardiovascular disease in the elderly. Kluwer Acad Publ, Boston, pp 253
Rigby JW, Scott AK, Hanksworth GM (1985) A comparison of the kinetics of atenolol, metoprolol, oxprenolol and propranolol in elderly hypertensive and young healthy subjects. Br J Clin Pharmacol 20: 327
Rodstein M (1956) The characteristics of nonfatal myocardial infarction in the aged. Arch Intern Med 98: 84
Rudolph W, Blasini R, Reiniger G, Brügmann U (1983) Tolerance development during isosorbide dinitrate treatment: can it be circumvented? Z Kardiol 72, Suppl 3: 195
Stern S, Gavish A, Zinn D (1988) Clinical outcome of silent myocardial ischemia. Am J Cardiol 62: 16 F
Swan HJC (1979) Mechanical function of the heart and its alteration during myocardial ischemia and infarction. Specific reference to coronary atherosclerosis. Circulation 60:1587
Tennant R, Wiggers CJ (1935) The effects of coronary occlusion on myocardial contraction. Am J Physiol 112:351
Thadani U, Mauyari B, Parker JO, Fung HL (1980) Tolerance to the circulatory effects of oral isosorbide dinitrate: rate of development and cross-tolerance to glyceryltrinitrate. Circulation 61: 526
The Multicenter Diltiazem Postinfarction Trial Research Group (1988) The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med 319:385
The Norwegian Multicenter Study Group (1981) Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 304:801
The TIMI Study Group (1989) Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) Phase II trial. N Engl J Med 320:618
Wei JY (1984) Heart disease in the elderly. Cardiovasc Med 9:971
Westerlund A (1985) Central nervous system side effects with hydrophilic and lipophilic beta blockers. Eur J Clin Pharmacol 28 (Suppl):73
Wittry MD, Thornton TA, Chaitman BR (1989) Safe use of thrombolysis in the elderly. Geriatrics 44:28
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kupper, W. (1993). Therapie der Koronaren Herzkrankheit. In: Platt, D. (eds) Pharmakotherapie und Alter. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77483-6_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-77483-6_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-77484-3
Online ISBN: 978-3-642-77483-6
eBook Packages: Springer Book Archive